We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$408M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
246
Reduced
378
Closed
79
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.82% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Constellation Brands
STZ
$21.9B
| $201M | 0.3% |
1,729,907
-277,752
| -14% | -$31.3M |
2013 Q2
7 quarters
|
|
|
VR
102
DELISTED
Validus Hold Ltd
VR
| $198M | 0.3% |
4,709,765
-1,108,352
| -19% | -$45.7M |
2013 Q2
7 quarters
|
|
103
Novartis
NVS
$286B
| $194M | 0.29% |
2,194,664
-372,117
| -14% | -$33M |
2013 Q4
5 quarters
|
|
104
Broadcom
AVGO
$1.64T
| $193M | 0.29% |
15,207,120
-865,030
| -5% | -$9.92M |
2013 Q4
5 quarters
|
|
105
Honeywell
HON
$66.7B
| $192M | 0.29% |
2,046,975
-175,053
| -8% | -$16M |
2013 Q2
7 quarters
|
|
106
Emerson Electric
EMR
$90.4B
| $191M | 0.29% |
3,381,103
-93,076
| -3% | -$5.41M |
2014 Q3
2 quarters
|
|
107
State Street
STT
$46B
| $191M | 0.28% |
2,595,197
-96,793
| -4% | -$7.25M |
2013 Q2
7 quarters
|
|
108
H&R Block
HRB
$5.92B
| $190M | 0.28% |
5,938,403
+182,664
| +3% | +$6.12M |
2014 Q4
1 quarter
|
|
109
L3Harris
LHX
$44.8B
| $190M | 0.28% |
2,415,460
+1,346,073
| +126% | +$98.2M |
2013 Q2
7 quarters
|
|
110
General Dynamics
GD
$91.2B
| $190M | 0.28% |
1,397,202
-33,943
| -2% | -$4.66M |
2014 Q4
1 quarter
|
|
111
Huntington Bancshares
HBAN
$31B
| $183M | 0.27% |
16,538,472
-8,367,634
| -34% | -$88.4M |
2013 Q2
7 quarters
|
|
112
Ally Financial
ALLY
$11.5B
| $182M | 0.27% |
+8,684,766
| New | +$183M |
2015 Q1
0 quarters
|
|
113
NetEase
NTES
$81.4B
| $181M | 0.27% |
8,605,775
+112,800
| +1% | +$2.38M |
2013 Q3
6 quarters
|
|
114
Reinsurance Group of America
RGA
$17.2B
| $180M | 0.27% |
1,927,746
-30,110
| -2% | -$2.66M |
2013 Q2
7 quarters
|
|
115
Motorola Solutions
MSI
$75.5B
| $179M | 0.27% |
2,679,382
-477,285
| -15% | -$31.6M |
2014 Q1
4 quarters
|
|
116
DELISTED
Six Flags Entertainment Corp.
SIX
| $175M | 0.26% |
3,618,256
-380,047
| -10% | -$17.3M |
2013 Q4
5 quarters
|
|
117
Loews
L
$22.2B
| $173M | 0.26% |
4,246,713
-62,872
| -1% | -$2.55M |
2013 Q2
7 quarters
|
|
118
Marsh
MRSH
$89B
| $172M | 0.26% |
3,059,590
-335,010
| -10% | -$18.9M |
2013 Q2
7 quarters
|
|
|
TSS
119
DELISTED
Total System Services, Inc.
TSS
| $171M | 0.25% |
4,485,672
+53,435
| +1% | +$1.96M |
2013 Q4
5 quarters
|
|
|
120
ExxonMobil
XOM
$718B
| $170M | 0.25% |
1,999,573
-3,660,397
| -65% | -$325M |
2013 Q2
7 quarters
|
|
121
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $169M | 0.25% |
2,938,852
+472,191
| +19% | +$26.1M |
2014 Q1
4 quarters
|
|
122
Icon
ICLR
$13.5B
| $166M | 0.25% |
2,351,910
+158,098
| +7% | +$9.8M |
2013 Q2
7 quarters
|
|
|
PE
123
DELISTED
PARSLEY ENERGY INC
PE
| $164M | 0.24% |
10,232,455
+2,984,158
| +41% | +$46.7M |
2014 Q2
3 quarters
|
|
124
SL Green Realty
SLG
$3.34B
| $163M | 0.24% |
1,315,279
+109,500
| +9% | +$13.5M |
2013 Q3
6 quarters
|
|
125
Kohl's
KSS
$2.54B
| $163M | 0.24% |
2,082,789
-169,374
| -8% | -$11.5M |
2013 Q2
7 quarters
|
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 246 increased, 378 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.